Home R&D Drug Delivery

Drug Delivery

Subcutaneous therapy for chronic inflammatory demyelinating polyneuropathy

Green light to gemtuzumab ozogamicin for acute myeloid leukemia

Gene therapy for transfusion-dependent β-thalassemia

New vaccine to protect adolescent and adult from Men B

Exceptional curcumstances approval for dinutuximab beta in neuroblastoma

New combo empagliflozin and linagliptin in type 2 diabetes

Palbociclib to treat breast cancer

Somatic cell therapy product for leukaemias and lymphomas

Eluxadoline for the treatment of irritable bowel syndrome with diarrhoea

Drug Discovery. Juicy fruits are on high branches

1234Page 1 of 4
© © 2024 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151